Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022

Neena Bitritto-Garg Initiated (AMLX) at Strong Buy and Held Target at $21 on, May 25th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-21-on-may-25th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Neena Bitritto-Garg of Citigroup, Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $21 on, May 25th, 2022.

Neena has made no other calls on AMLX in the last 4 months.



There are 4 other peers that have a rating on AMLX. Out of the 4 peers that are also analyzing AMLX, 1 agrees with Neena's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $10 on, Friday, April 1st, 2022


These are the ratings of the 3 analyists that currently disagree with Neena


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $31 on, Thursday, March 31st, 2022
  • Umer Raffat of "Evercore ISI Group" Initiated at Buy on, Wednesday, February 2nd, 2022
  • Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Tuesday, February 1st, 2022

Publication Contributing Sources